## KMX: CarMax, Inc. - XLY: Consumer Cyclical

### Executive Summary

VALUE thesis: PEG 0.69 indicates fundamental undervaluation. Caution: declining volume (49% of avg).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($35.60)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Bearish (Bullish: 0, Bearish: 10)

**1. Class Action Filed Against CarMax, Inc. (KMX) - January 2, 2026 Deadline to Join - Contact The Gross Law Firm**
- Source: FOX 2 | 20251204T230816 | Bearish | Relevance: 100%
- The Gross Law Firm has announced a class action lawsuit against CarMax, Inc. (KMX), urging shareholders who purchased shares between June 20, 2025, and November 5, 2025, to come forward. The complaint alleges that CarMax overstated its growth prospects, which were temporarily boosted by speculation regarding tariffs in the 2026 fiscal year. Shareholders have until January 2, 2026, to register to potentially be appointed as lead plaintiff.

**2. Class Action Filed Against CarMax, Inc. (KMX) - January 2, 2026 Deadline to Join â€“ Contact The Gross Law Firm**
- Source: GlobeNewswire | 20251204T170841 | Bearish | Relevance: 100%
- The Gross Law Firm has issued a notice to shareholders of CarMax, Inc. (NYSE: KMX) regarding a class action lawsuit. Shareholders who purchased KMX shares between June 20, 2025, and November 5, 2025, are encouraged to contact the firm, as defendants allegedly made false or misleading statements about CarMax's growth prospects. The deadline to seek lead plaintiff appointment is January 2, 2026.

**3. CarMax Shareholder Alert: ClaimsFiler Reminds Investors**
- Source: GlobeNewswire | 20251204T152027 | Bearish | Relevance: 100%
- ClaimsFiler is reminding CarMax investors that they have until January 2, 2026, to file lead plaintiff applications in a securities class action lawsuit against CarMax, Inc. (NYSE: KMX). The lawsuit alleges that CarMax and its executives failed to disclose material information during the Class Period, particularly regarding a decrease in sales and net earnings, which led to a significant drop in share price. Investors who purchased CarMax securities between June 20, 2025, and November 5, 2025, are affected.

**4. KMX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that CarMax, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!**
- Source: KTLA | 20251204T120838 | Bearish | Relevance: 100%
- Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit against CarMax, Inc. (NYSE: KMX) for alleged violations of federal securities laws. The lawsuit claims that CarMax and certain officers made false or misleading statements regarding the company's growth prospects between June 20, 2025, and November 5, 2025. Investors who purchased CarMax securities during this period have until January 2, 2026, to request to be appointed as lead plaintiff.

**5. KMX ANNOUNCEMENT: Kessler Topaz Meltzer & Check, LLP**
- Source: GlobeNewswire | 20251204T103700 | Bearish | Relevance: 100%
- Kessler Topaz Meltzer & Check, LLP announced an amended securities class action lawsuit against CarMax, Inc. (KMX), expanding the class period to include investors who purchased securities between June 20, 2025, and November 5, 2025. The lawsuit alleges CarMax made misleading statements regarding its growth prospects, which were reportedly a temporary benefit from customers buying cars due to tariff speculation. Investors who suffered losses have until January 2, 2026, to seek lead plaintiff status.

### Analyst Activity

**Target Signal:** VERY_BEARISH (Raises: 0, Lowers: 5)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-18 | Wedbush | $40 | $40 | 0% |
| 2025-11-12 | Barclays | $28 | $0 | 0% |
| 2025-11-10 | Morgan Stanley | $35 | $56 | -38% |
| 2025-11-07 | RBC Capital | $34 | $59 | -42% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-18 | Wedbush | reit | Neutral |
| 2025-11-12 | Barclays | init | Underweight |
| 2025-11-10 | Morgan Stanley | down | Equal-Weight |
| 2025-11-07 | RBC Capital | down | Sector Perform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 2 ($0.59M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 43.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 11.9% (-3.8%)
- Blackrock Inc.: 8.1% (+5.9%)
- State Street Corpora: 3.9% (-2.2%)
- Janus Henderson Grou: 3.4% (+1.0%)
- Diamond Hill Capital: 3.4% (-30.6%)

### Key Risks

1. Elevated short interest (10.7%): bears positioning against stock.
2. Long-term trend broken: trading 35.1% below SMA200.
3. Falling knife pattern: rapid decline without stabilization, catch risk elevated.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_20 improving +1.2% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 0.69 indicates undervaluation relative to growth. Balance sheet: $1.1B free cash flow. Analyst sentiment negative (5 target cuts vs 0 raises). Insider buying signal ($0.6M), management confidence. Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $5.8B |
| Beta | 1.29 |
| 52W Range | $30.26 - $89.47 |
| Short Interest | 10.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.69 |
| Forward P/E | 15.1 |
| Current P/E | 14.6 |
| YoY Growth | -3.2% |
| EPS Direction | FALLING |

### Technicals

MRS_20 strengthening from 6.4% to 7.6% (+1.2% in 5 days), confirming momentum buildup. Currently in upper STRENGTH zone (4.0-10.0%), cross-sectional ranking at 92nd percentile. MRS_5 (-0.1%) diverging from MRS_20 - short-term weakness emerging. AM_20 at 9.9% shows strong absolute momentum above own 20MA. Outperforming sector by 7.5pp, stock-specific strength. Below SMA200 (0.65x), long-term trend not supportive. MACD histogram positive (0.96), confirming momentum. RSI neutral at 53. Volume at 49% of 20MA suggests lack of conviction. OFD pattern: -SLL (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 7.64% (CS: 92) | Strong |
| RSI_14 | 52.6 | Neutral |
| MACD Histogram | 0.96 | Bullish |
| vs SMA20 | 1.099x | Above |
| vs SMA50 | 0.960x | Below |
| vs SMA200 | 0.649x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $38.90
- **Stop Loss:** $35.60 (8.5% risk)
- **Target:** $45.50 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 303
- **Position Value:** $11,786.70
- **Portfolio %:** 11.79%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at 15.78 indicates calm conditions but breadth at 53% suggests narrow participation. Fed policy remains neutral with 42 days to next meeting, supporting steady positioning with sector selectivity.*

### Earnings

**Next:** 2025-12-18 (Est: $0.31)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $0.32 | $0.43 | +36.1% |
| 2025Q3 | $1.04 | $0.64 | -38.6% |
| 2025Q2 | $1.17 | $1.38 | +18.3% |
| 2025Q1 | $0.66 | $0.58 | -12.3% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*